Search | IOVS | ARVO Journals

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

TLR2 bridges oxidative damage and complement-associated pathology and is a therapeutic target for age-related macular degeneration.

Sarah Doyle; Kelly Mulfaul; Nilisha Fernando; Kathleen Chirco; Emma Connolly; Tony Ryan; Ema Ozaki; Kiva Brennan; Arvydas Maminishkis; Robert Salomon; Riccardo Natoli; Robert F Mullins; Matthew Campbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3475. doi:

ARVO Annual Meeting Abstract September 2016

Investigating a role for Toll like receptor signaling in the pathogenesis of Age Related Macular Degeneration (AMD).

Kelly Mulfaul; Ema Ozaki; Kiva Brennan; Matthew Campbell; Sarah Doyle

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5010. doi:

Biochemistry and Molecular Biology August 2015

IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates

PDF

Sarah L. Doyle; Francisco J. López; Lucia Celkova; Kiva Brennan; Kelly Mulfaul; Ema Ozaki; Paul F. Kenna; Edit Kurali; Natalie Hudson; Teresa Doggett; Thomas A. Ferguson; Peter Humphries; Peter Adamson; Matthew Campbell
TAGS: immunotherapy, interleukin-18, primates, exudative age-related macular degeneration
Invest. Ophthalmol. Vis. Sci.. 2015; 56(9):5424-5430. doi: 10.1167/iovs.15-17264

Includes: Supplemental Content

Advertisement